You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output.
Click here to find out more.
X Demographics
Mendeley readers
Attention Score in Context
| Title |
Effect of Long-term, Low-Dose Erythromycin on Pulmonary Exacerbations Among Patients With Non–Cystic Fibrosis Bronchiectasis: The BLESS Randomized Controlled Trial
|
|---|---|
| Published in |
JAMA: Journal of the American Medical Association, March 2013
|
| DOI | 10.1001/jama.2013.2290 |
| Pubmed ID | |
| Authors |
David J. Serisier, Megan L. Martin, Michael A. McGuckin, Rohan Lourie, Alice C. Chen, Barbara Brain, Sally Biga, Sanmarié Schlebusch, Peter Dash, Simon D. Bowler |
| Abstract |
Macrolide antibiotics such as erythromycin may improve clinical outcomes in non-cystic fibrosis (CF) bronchiectasis, although associated risks of macrolide resistance are poorly defined. |
X Demographics
The data shown below were collected from the profiles of 9 X users who shared this research output. Click here to find out more about how the information was compiled.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| United States | 2 | 22% |
| Spain | 1 | 11% |
| Unknown | 6 | 67% |
Demographic breakdown
| Type | Count | As % |
|---|---|---|
| Members of the public | 8 | 89% |
| Practitioners (doctors, other healthcare professionals) | 1 | 11% |
Mendeley readers
The data shown below were compiled from readership statistics for 218 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| Canada | 2 | <1% |
| France | 1 | <1% |
| United Kingdom | 1 | <1% |
| Spain | 1 | <1% |
| Japan | 1 | <1% |
| Greece | 1 | <1% |
| United States | 1 | <1% |
| Unknown | 210 | 96% |
Demographic breakdown
| Readers by professional status | Count | As % |
|---|---|---|
| Student > Ph. D. Student | 33 | 15% |
| Other | 27 | 12% |
| Researcher | 24 | 11% |
| Student > Master | 19 | 9% |
| Student > Bachelor | 18 | 8% |
| Other | 41 | 19% |
| Unknown | 56 | 26% |
| Readers by discipline | Count | As % |
|---|---|---|
| Medicine and Dentistry | 115 | 53% |
| Pharmacology, Toxicology and Pharmaceutical Science | 9 | 4% |
| Nursing and Health Professions | 8 | 4% |
| Agricultural and Biological Sciences | 7 | 3% |
| Immunology and Microbiology | 5 | 2% |
| Other | 14 | 6% |
| Unknown | 60 | 28% |
Attention Score in Context
This research output has an Altmetric Attention Score of 45. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 10 February 2022.
All research outputs
#930,289
of 25,373,627 outputs
Outputs from JAMA: Journal of the American Medical Association
#8,070
of 36,409 outputs
Outputs of similar age
#6,581
of 210,265 outputs
Outputs of similar age from JAMA: Journal of the American Medical Association
#57
of 242 outputs
Altmetric has tracked 25,373,627 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 96th percentile: it's in the top 5% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 36,409 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 72.6. This one has done well, scoring higher than 77% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 210,265 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 96% of its contemporaries.
We're also able to compare this research output to 242 others from the same source and published within six weeks on either side of this one. This one has done well, scoring higher than 76% of its contemporaries.